ERBB2 and invasive lobular breast carcinoma: This has been explained by the greater propensity of invasive lobular carcinoma to have several genomic alterations which include phosphatidylinositol 3-kinases (PI3K) pathways and mutations in HER2, HER3 and estrogen receptor 1α(ESR1) genes, amongst other factors [12].